Importer of Controlled Substances Application: Purisys, LLC, 14471-14472 [2021-05356]
Download as PDF
14471
Federal Register / Vol. 86, No. 49 / Tuesday, March 16, 2021 / Notices
from CY 2020 to CY 2021, and such that
no area has a factor less than one. For
PHAs operating in multiple FMR areas,
HUD calculates a voucher-weighted
average inflation factor based on the
count of vouchers in each FMR area
administered by the PHA as captured in
HUD administrative data as of December
31, 2020.
National Environmental Policy Act of
1969 (42 U.S.C. 4321).
III. The Use of Inflation Factors
DEPARTMENT OF JUSTICE
HUD subsequently applies the
calculated individual area inflation
factors to eligible renewal funding for
each PHA based on VMS leasing and
cost data for the prior calendar year.
Drug Enforcement Administration
jbell on DSKJLSW7X2PROD with NOTICES
Drug Enforcement
Administration, Justice.
ACTION: Notice of application;
correction.
AGENCY:
VI. Environmental Impact
This notice involves a statutorily
required establishment of a rate or cost
determination which does not constitute
a development decision affecting the
physical condition of specific project
areas or building sites. Accordingly,
under 24 CFR 50.19(c)(6), this notice is
categorically excluded from
environmental review under the
Jkt 253001
BILLING CODE 4210–67–P
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotope Lab; Correction
As explained above, inflation factors
based on area FMR changes are
produced for all FMR areas and applied
to eligible renewal funding for each
PHA. The tables showing the RFIFs,
available electronically from the HUD
data information page, list the inflation
factors for each FMR area on a state-bystate basis. The inflation factors use the
same OMB metropolitan area
definitions, as revised by HUD, that are
used in the FY 2021 FMRs. PHAs
should refer to the Area Definitions
Table on the following web page to
make certain that they are referencing
the correct inflation factors: https://
www.huduser.org/portal/datasets/rfif/
FY2021/FY2021_RFIF_FMR_AREA_
REPORT.pdf. The Area Definitions
Table lists areas in alphabetical order by
state, and the counties associated with
each area. In the six New England states,
the listings are for counties or parts of
counties as defined by towns or cities.
HUD is also releasing the data in
Microsoft Excel format to assist users
who may wish to use these data in other
calculations. The Excel file is available
at https://www.huduser.gov/portal/
datasets/rfif/rfif.html. Note that, as
described earlier, the actual renewal
funding inflation factor applied to
agency funding will be the voucherweighted average of the FMR area
factors when the PHA operates in
multiple areas.
16:52 Mar 15, 2021
[FR Doc. 2021–05365 Filed 3–15–21; 8:45 am]
[Docket No. DEA–709]
IV. Geographic Areas and Area
Definitions
VerDate Sep<11>2014
Todd Richardson,
General Deputy Assistant Secretary for Policy,
Development and Research.
The Drug Enforcement
Administration (DEA) published a
document in the Federal Register of
September 14, 2020, concerning a notice
of application. The document contained
a misspelling (Isotype vs. Isotope).
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of September
14, 2020, in FR Doc. 2020–20160 (85 FR
56633), on page 56633–56634, correct
all instances of the registrant name to
read Cambridge Isotope Lab.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–05358 Filed 3–15–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–805]
Importer of Controlled Substances
Application: Purisys, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Purisys, LLC has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before April 15, 2021. Such persons
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on February 17, 2021,
Purisys, LLC, 1550 Olympic Drive,
Athens, Georgia 30601, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
SUMMARY:
DATES:
may also file a written request for a
hearing on the application on or before
April 15, 2021.
Marihuana Extract .............
Marihuana .........................
Tetrahydrocannabinols .....
Noroxymorphone ..............
Phenylacetone ..................
Levorphanol ......................
Thebaine ...........................
Poppy Straw Concentrate
Tapentadol ........................
7350
7360
7370
7379
8501
9220
9333
9670
9780
I
I
I
II
II
II
II
II
II
The company plans to import drug
code 8501, Phenylacetone and drug
code 9670, Poppy Straw Concentrate to
bulk manufacture other controlled
substances for distribution to its
customers. The company plans to
import impurities of buprenorphine that
have been determined by DEA to be
captured under drug code 9333,
Thebaine. In reference to drug codes
73760, Marihuana and 7370,
Tetrahydrocannabinols the company
plans to import a Synthetic Cannabidiol
and a Synthetic Tetrahydrocannabinol.
No other activity for these drug codes is
authorized for this registration.
Placement of these drug codes on the
company’s registration does not
translate into automatic approval of
subsequent permit applications to
import controlled substances.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
E:\FR\FM\16MRN1.SGM
16MRN1
14472
Federal Register / Vol. 86, No. 49 / Tuesday, March 16, 2021 / Notices
the novel coronavirus (COVID–19).
Schedule updates, including weatherrelated cancellations, are also available
at www.ntsb.gov.
The National Transportation Safety
Board is holding this meeting under the
Government in the Sunshine Act, 5
U.S.C. 552(b).
approved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–05356 Filed 3–15–21; 8:45 am]
BILLING CODE 4410–09–P
NATIONAL CREDIT UNION
ADMINISTRATION
Dated: March 12, 2021.
Candi R. Bing,
Federal Register Liaison Officer.
Sunshine Act Meetings
[FR Doc. 2021–05551 Filed 3–12–21; 4:50 pm]
10:00 a.m., Thursday,
March 18, 2021.
PLACE: Due to the COVID–19 Pandemic,
the meeting will be open to the public
via live webcast only. Visit the agency’s
homepage (www.ncua.gov) and access
the provided webcast link.
STATUS: This meeting will be open to the
public.
MATTERS TO BE CONSIDERED:
1. NCUA Rules and Regulations,
Central Liquidity Facility.
2. NCUA Rules and Regulations, Asset
Thresholds Pertaining to Large Credit
Unions.
3. Board Briefing, NCUA Guaranteed
Note and Asset Management Estates
Programs.
CONTACT PERSON FOR MORE INFORMATION:
Melane Conyers-Ausbrooks, Secretary of
the Board, Telephone: 703–518–6304.
BILLING CODE 7533–01–P
TIME AND DATE:
Melane Conyers-Ausbrooks,
Secretary of the Board.
[FR Doc. 2021–05468 Filed 3–12–21; 11:15 am]
BILLING CODE 7535–01–P
NATIONAL TRANSPORTATION
SAFETY BOARD
Sunshine Act Meeting
9:30 a.m., Tuesday, April
6, 2021.
PLACE: Virtual.
STATUS: The one item may be viewed by
the public through webcast only.
MATTER TO BE CONSIDERED:
66392 2021–2022 Most Wanted List
of Transportation Safety
Improvements Proposal.
FOR MORE INFORMATION CONTACT: Candi
Bing at (202) 590–8384 or by email at
bingc@ntsb.gov.
Media Information Contact: Chris
O’Neil by email at chris.oneil@ntsb.gov
(202) 314–6100.
This meeting will take place virtually.
The public may view it through a live
or archived webcast by accessing a link
under ‘‘Webcast of Events’’ on the NTSB
home page at www.ntsb.gov.
There may be changes to this event
due to the evolving situation concerning
jbell on DSKJLSW7X2PROD with NOTICES
TIME AND DATE:
VerDate Sep<11>2014
16:52 Mar 15, 2021
Jkt 253001
NUCLEAR REGULATORY
COMMISSION
[Docket Nos. 50–289 and 50–320; NRC–
2021–0069]
Exelon Generation Company, LLC;
TMI-2 Solutions, LLC; Three Mile Island
Nuclear Station, Units 1 and 2
Nuclear Regulatory
Commission.
ACTION: Exemptions; issuance.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) has issued
exemptions in response to a request to
reduce the required level of primary
offsite liability insurance from $450
million to $100 million and to eliminate
the requirement to carry secondary
financial protection for Three Mile
Island Nuclear Station, Unit 1 and to
reduce the required level of primary
offsite liability insurance in the event of
an extraordinary nuclear occurrence
from $200 million to $100 million for
Three Mile Island Nuclear Station, Unit
2.
DATES: The exemptions were issued on
March 9, 2021.
ADDRESSES: Please refer to Docket ID
NRC–2021–0069 when contacting the
NRC about the availability of
information regarding this document.
You may obtain publicly available
information related to this document
using any of the following methods:
• Federal Rulemaking website: Go to
https://www.regulations.gov and search
for Docket ID NRC–2021–0069. Address
questions about Docket IDs in
Regulations.gov to Stacy Schumann;
telephone: 301–415–0624; email:
Stacy.Schumann@nrc.gov. For technical
questions, contact the individual listed
in the FOR FURTHER INFORMATION
CONTACT section of this document.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
SUMMARY:
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to pdr.resource@
nrc.gov. The ADAMS accession number
for each document referenced (if it is
available in ADAMS) is provided the
first time that it is mentioned in this
document.
• Attention: The PDR, where you may
examine and order copies of public
documents, is currently closed. You
may submit your request to the PDR via
email at pdr.resource@nrc.gov or call
1–800–397–4209 or 301–415–4737,
between 8:00 a.m. and 4:00 p.m. (EST),
Monday through Friday, except Federal
holidays.
FOR FURTHER INFORMATION CONTACT:
Theodore Smith, Office of Nuclear
Material Safety and Safeguards, U.S.
Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–6721, email: Theodore.Smith@
nrc.gov.
SUPPLEMENTARY INFORMATION: The text of
the exemptions is attached.
Dated: March 11, 2021.
For the Nuclear Regulatory Commission.
Bruce A. Watson,
Chief, Reactor Decommissioning Branch,
Division of Decommissioning, Uranium
Recovery and Waste Programs, Office of
Nuclear Material Safety and Safeguards.
Attachment—Exemption
NUCLEAR REGULATORY
COMMISSIOIN
Docket Nos. 50–289 and 50–320
Exelon Generation Company, LLC
TMI-2 Solutions, LLC
Three Mile Island Nuclear Station,
Units 1 and 2 Exemptions
I. Background
By letter dated June 20, 2017
(Agencywide Documents Access and
Management System [ADAMS]
Accession No. Main Library [ML]
ML17171A151), Exelon Generation
Company, LLC (Exelon) certified to the
U.S. Nuclear Regulatory Commission
(NRC, the Commission) that it planned
to permanently cease power operations
at Three Mile Island Nuclear Station,
Unit 1 (TMI-1) on or about September
30, 2019. On September 20, 2019,
Exelon permanently ceased power
operations at TMI-1. By letter dated
September 26, 2019 (ADAMS Accession
No. ML19269E480), Exelon certified to
the NRC that the fuel was permanently
removed from the TMI-1 reactor vessel
and placed in the spent fuel pool (SFP)
as of September 26, 2019. Accordingly,
E:\FR\FM\16MRN1.SGM
16MRN1
Agencies
[Federal Register Volume 86, Number 49 (Tuesday, March 16, 2021)]
[Notices]
[Pages 14471-14472]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-05356]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-805]
Importer of Controlled Substances Application: Purisys, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Purisys, LLC has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before April 15, 2021.
Such persons may also file a written request for a hearing on the
application on or before April 15, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on February 17, 2021, Purisys, LLC, 1550 Olympic Drive,
Athens, Georgia 30601, applied to be registered as an importer of the
following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
------------------------------------------------------------------------
Marihuana Extract..................... 7350 I
Marihuana............................. 7360 I
Tetrahydrocannabinols................. 7370 I
Noroxymorphone........................ 7379 II
Phenylacetone......................... 8501 II
Levorphanol........................... 9220 II
Thebaine.............................. 9333 II
Poppy Straw Concentrate............... 9670 II
Tapentadol............................ 9780 II
------------------------------------------------------------------------
The company plans to import drug code 8501, Phenylacetone and drug
code 9670, Poppy Straw Concentrate to bulk manufacture other controlled
substances for distribution to its customers. The company plans to
import impurities of buprenorphine that have been determined by DEA to
be captured under drug code 9333, Thebaine. In reference to drug codes
73760, Marihuana and 7370, Tetrahydrocannabinols the company plans to
import a Synthetic Cannabidiol and a Synthetic Tetrahydrocannabinol. No
other activity for these drug codes is authorized for this
registration. Placement of these drug codes on the company's
registration does not translate into automatic approval of subsequent
permit applications to import controlled substances.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-
[[Page 14472]]
approved finished dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-05356 Filed 3-15-21; 8:45 am]
BILLING CODE 4410-09-P